Hong Kong · Delayed Price · Currency is HKD CanSino Biologics Statistics
Total Valuation
HKG:6185 has a market cap or net worth of HKD 13.81 billion. The enterprise value is 12.82 billion.
| Market Cap | 13.81B |
| Enterprise Value | 12.82B |
Important Dates
The last earnings date was Tuesday, October 27, 2026.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:6185 has 247.04 million shares outstanding. The number of shares has increased by 1.91% in one year.
| Current Share Class | 132.67M |
| Shares Outstanding | 247.04M |
| Shares Change (YoY) | +1.91% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 31.01% |
| Owned by Institutions (%) | 9.87% |
| Float | 160.04M |
Valuation Ratios
The trailing PE ratio is 190.00 and the forward PE ratio is 21.43.
| PE Ratio | 190.00 |
| Forward PE | 21.43 |
| PS Ratio | 9.39 |
| PB Ratio | 2.36 |
| P/TBV Ratio | 2.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 350.99 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 368.63 |
| EV / Sales | 8.71 |
| EV / EBITDA | 139.58 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.23, with a Debt / Equity ratio of 0.19.
| Current Ratio | 4.23 |
| Quick Ratio | 3.65 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 11.84 |
| Debt / FCF | n/a |
| Interest Coverage | -3.70 |
Financial Efficiency
Return on equity (ROE) is 0.60% and return on invested capital (ROIC) is -1.34%.
| Return on Equity (ROE) | 0.60% |
| Return on Assets (ROA) | -0.60% |
| Return on Invested Capital (ROIC) | -1.34% |
| Return on Capital Employed (ROCE) | -1.11% |
| Weighted Average Cost of Capital (WACC) | 10.02% |
| Revenue Per Employee | 1.30M |
| Profits Per Employee | 30,663 |
| Employee Count | 1,175 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 0.85 |
Taxes
In the past 12 months, HKG:6185 has paid 7.64 million in taxes.
| Income Tax | 7.64M |
| Effective Tax Rate | 18.02% |
Stock Price Statistics
The stock price has decreased by -41.14% in the last 52 weeks. The beta is 1.17, so HKG:6185's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | -41.14% |
| 50-Day Moving Average | 29.44 |
| 200-Day Moving Average | 29.19 |
| Relative Strength Index (RSI) | 44.01 |
| Average Volume (20 Days) | 3,708,396 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:6185 had revenue of HKD 1.47 billion and earned 34.77 million in profits. Earnings per share was 0.14.
| Revenue | 1.47B |
| Gross Profit | 1.09B |
| Operating Income | -79.14M |
| Pretax Income | 42.41M |
| Net Income | 34.77M |
| EBITDA | 85.27M |
| EBIT | -79.14M |
| Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has 2.08 billion in cash and 1.09 billion in debt, with a net cash position of 989.59 million or 4.01 per share.
| Cash & Cash Equivalents | 2.08B |
| Total Debt | 1.09B |
| Net Cash | 989.59M |
| Net Cash Per Share | 4.01 |
| Equity (Book Value) | 5.86B |
| Book Value Per Share | n/a |
| Working Capital | 2.89B |
Cash Flow
In the last 12 months, operating cash flow was 39.34 million and capital expenditures -185.99 million, giving a free cash flow of -146.65 million.
| Operating Cash Flow | 39.34M |
| Capital Expenditures | -185.99M |
| Depreciation & Amortization | 165.31M |
| Net Borrowing | -591.35M |
| Free Cash Flow | -146.65M |
| FCF Per Share | -0.59 |
Margins
Gross margin is 74.08%, with operating and profit margins of -5.38% and 2.36%.
| Gross Margin | 74.08% |
| Operating Margin | -5.38% |
| Pretax Margin | 2.88% |
| Profit Margin | 2.36% |
| EBITDA Margin | 5.80% |
| EBIT Margin | -5.38% |
| FCF Margin | n/a |
Dividends & Yields
HKG:6185 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 88.68% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.91% |
| Shareholder Yield | -1.91% |
| Earnings Yield | 0.53% |
| FCF Yield | -1.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for HKG:6185 is 42.86, which is 60.52% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 42.86 |
| Price Target Difference | 60.52% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 28.28% |
| EPS Growth Forecast (3Y) | 162.45% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:6185 has an Altman Z-Score of 4.19 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.19 |
| Piotroski F-Score | 6 |